Why the study?
Patients continue to suffer from heart failure symptoms despite biventricular pacing, which does not restore physiological activation and yields disappointing results in non-LBBB disease.
Do alternative pacing approaches like conduction system pacing provide more effective cardiac resynchronization therapy compared to biventricular pacing in patients with heart failure?
Do alternative pacing approaches like conduction system pacing provide more effective cardiac resynchronization therapy compared to biventricular pacing in patients with heart failure?
Answers are grounded in this paper and cite their sources.
Alternative pacing strategies like conduction system pacing may overcome the limitations of traditional biventricular pacing by restoring more physiological ventricular activation in heart failure patients.
INTRODUCTION: Cardiac resynchronization therapy (CRT) has been developed as a treatment for patients with conduction system dysfunction and impairment of ventricular performance. The aim is to restore more physiological cardiac activation and thereby improve cardiac function, symptoms, and outcomes. AREAS COVERED: In this review, we discuss potential electrical treatment targets for patients with heart failure and how these electrical treatment targets may determine the optimal pacing approach for delivering CRT. EXPERT OPINION: The most well-established method for delivering CRT is biventricular pacing (BVP). BVP improves symptoms and reduces mortality in patients with left bundle branch block (LBBB). However, patients continue to suffer from heart failure symptoms and decompensations despite receiving BVP. There may be scope to deliver more effective CRT since BVP does not restore physiological ventricular activation. Furthermore, the results with BVP in patients with non-LBBB conduction system disease have been generally disappointing. Alternative pacing approaches to BVP are now available, including conduction system pacing and left ventricular endocardial pacing. These newer pacing approaches offer exciting potential to not only offer an alternative to coronary sinus lead implantation in the case of implant failure but to potentially deliver more effective treatment in LBBB and maybe even extend the indications for CRT beyond LBBB.
No takes yet. Share an insight, caveat, or question.
Simader et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: